| Mr William A White, MD | |
|
7500 State Line Road, Suite 100, Prairie Village, KS 66208 | |
| (913) 588-6605 | |
| (913) 588-0888 |
| Full Name | Mr William A White |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 18 Years |
| Location | 7500 State Line Road, Prairie Village, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912168519 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 04-34862 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
With substandard and counterfeit versions of medicines intended to treat life-threatening diseases such as malaria, HIV/AIDS and tuberculosis posing a growing threat throughout the developing world, the U.S. Agency for International Development (USAID) and the U.S. Pharmacopeial Convention (USP) will expand their joint efforts to combat this menace by launching a new program over the next five years.
For many women, the decision to get pregnant can take on a life of its own. In fact, according to a survey conducted for SpermCheck- Fertility, 42% of those who conceived say they became obsessed with getting pregnant once they started trying. Yet just 10% say their partner shared this obsession.
The preliminary analysis of penalties would lower Medicare payments to these hospitals by 1 percent for a year. Elsewhere, lawmakers introduce legislation to change how hospitals that serve a large number of poor patients are affected by Medicare's penalties.
The National Institutes of Health has renewed its prestigious Clinical and Translational Science Award (CTSA) with the Scripps Translational Science Institute (STSI) in the amount of $29 million over the next five years to support innovative research in genomics, wireless technology and bioinformatics toward individualizing medicine.
Allos Therapeutics, Inc. today announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory cutaneous T-cell lymphoma, a group of often slow-growing non-Hodgkins lymphomas that primarily manifest in the skin. These data were presented during a poster presentation at the European Hematology Association meeting being held June 10-13, 2010 in Barcelona, Spain.
› Verified 8 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
With substandard and counterfeit versions of medicines intended to treat life-threatening diseases such as malaria, HIV/AIDS and tuberculosis posing a growing threat throughout the developing world, the U.S. Agency for International Development (USAID) and the U.S. Pharmacopeial Convention (USP) will expand their joint efforts to combat this menace by launching a new program over the next five years.
For many women, the decision to get pregnant can take on a life of its own. In fact, according to a survey conducted for SpermCheck- Fertility, 42% of those who conceived say they became obsessed with getting pregnant once they started trying. Yet just 10% say their partner shared this obsession.
The preliminary analysis of penalties would lower Medicare payments to these hospitals by 1 percent for a year. Elsewhere, lawmakers introduce legislation to change how hospitals that serve a large number of poor patients are affected by Medicare's penalties.
The National Institutes of Health has renewed its prestigious Clinical and Translational Science Award (CTSA) with the Scripps Translational Science Institute (STSI) in the amount of $29 million over the next five years to support innovative research in genomics, wireless technology and bioinformatics toward individualizing medicine.
Allos Therapeutics, Inc. today announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory cutaneous T-cell lymphoma, a group of often slow-growing non-Hodgkins lymphomas that primarily manifest in the skin. These data were presented during a poster presentation at the European Hematology Association meeting being held June 10-13, 2010 in Barcelona, Spain.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr William A White, MD Po Box 411851, Kansas City, MO 64141-1851 Ph: (913) 588-6605 | Mr William A White, MD 7500 State Line Road, Suite 100, Prairie Village, KS 66208 Ph: (913) 588-6605 |
News Archive
With substandard and counterfeit versions of medicines intended to treat life-threatening diseases such as malaria, HIV/AIDS and tuberculosis posing a growing threat throughout the developing world, the U.S. Agency for International Development (USAID) and the U.S. Pharmacopeial Convention (USP) will expand their joint efforts to combat this menace by launching a new program over the next five years.
For many women, the decision to get pregnant can take on a life of its own. In fact, according to a survey conducted for SpermCheck- Fertility, 42% of those who conceived say they became obsessed with getting pregnant once they started trying. Yet just 10% say their partner shared this obsession.
The preliminary analysis of penalties would lower Medicare payments to these hospitals by 1 percent for a year. Elsewhere, lawmakers introduce legislation to change how hospitals that serve a large number of poor patients are affected by Medicare's penalties.
The National Institutes of Health has renewed its prestigious Clinical and Translational Science Award (CTSA) with the Scripps Translational Science Institute (STSI) in the amount of $29 million over the next five years to support innovative research in genomics, wireless technology and bioinformatics toward individualizing medicine.
Allos Therapeutics, Inc. today announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory cutaneous T-cell lymphoma, a group of often slow-growing non-Hodgkins lymphomas that primarily manifest in the skin. These data were presented during a poster presentation at the European Hematology Association meeting being held June 10-13, 2010 in Barcelona, Spain.
› Verified 8 days ago
Miles Greenwald, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7400 State Line Rd, Prairie Village, KS 66208 Phone: 913-588-6600 | |
Stephen Longshore Ambrose, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7400 State Line Rd, Prairie Village, KS 66208 Phone: 913-588-6600 Fax: 913-588-6655 | |
Dr. Raymond E Kandt Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4950 W 88th St, Prairie Village, KS 66207 Phone: 913-381-4544 | |
Jason Aaron Sokol, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7400 State Line Rd, Suite 100, Prairie Village, KS 66208 Phone: 913-588-6605 Fax: 913-588-0888 | |
Andrew Kalina, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 7400 State Line Rd, Prairie Village, KS 66208 Phone: 913-588-6660 Fax: 913-588-0888 | |
Dr. Miranda Nabil Bishara, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7400 State Line Rd, Suite 100, Prairie Village, KS 66208 Phone: 913-588-6600 Fax: 913-588-6655 | |
Steven R Unterman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3830 W 75th St, Prairie Village, KS 66208 Phone: 913-384-1441 Fax: 913-384-3437 |